These findings provide new targets and research directions for future ICC therapy, suggesting that METTL1/WDR4-mediated m7G tRNA modification plays an important role in the progression of ICC (Luo et al., 2022). This evidence concerns the gene WDR4 and intrahepatic cholangiocarcinoma.